Why Do I Keep Getting Styes? The Underlying Causes Most Miami Patients Haven’t Been Told About
A stye is painful, inconvenient, and visually obvious in ways that affect daily life for the week or two it takes to resolve. Most people who get one treat it with warm compresses, wait it out, and move on. The problem develops when the stye comes back. And then comes back again.
Recurring styes are not bad luck. They are a symptom of an underlying condition that warm compresses and time do not address. Understanding what that condition is, and treating it specifically, is what actually stops the cycle.
What a Stye Actually Is
A stye, medically called a hordeolum, forms when one of the glands along the eyelid margin becomes blocked and infected. The meibomian glands, which run vertically through the eyelid and open at the lid margin, produce the oil component of the tear film. When their openings become obstructed, the accumulated secretion creates an environment where bacteria, most commonly Staphylococcus, proliferate and produce the painful, localized swelling that characterizes a stye.
The external stye develops at the base of a lash follicle. The internal stye develops further back in the lid, directly at a meibomian gland opening. Both share the same fundamental mechanism: a blocked gland in an environment where bacteria can establish an infection.
A single stye, particularly in someone who has never had one before, is often an isolated event. Recurrent styes in the same or different locations are a different clinical picture, one that points toward a persistent condition affecting the lid margins and glands rather than a one-time obstruction.
Blepharitis: The Most Common Underlying Driver
Blepharitis is chronic inflammation of the eyelid margins, and it is the most common reason patients develop recurring styes. The condition involves the accumulation of debris, excess oil, and bacterial biofilm at the base of the lashes and along the lid margin, creating the chronic obstruction that blocks meibomian gland openings repeatedly.
The bacteria most associated with blepharitis, particularly Staphylococcus species, produce toxins that directly irritate the lid margin and contribute to both the inflammatory cycle and the gland blockage that produces styes. A patient with untreated blepharitis is living with the exact conditions that cause styes to form, continuously and persistently.
Blepharitis is also a condition that doesn’t resolve on its own. Without consistent lid hygiene and in some cases antibiotic or anti-inflammatory treatment, the bacterial biofilm and debris that characterize the condition rebuild after each cleaning. Patients who treat their stye without addressing the underlying blepharitis are treating the consequence rather than the cause, and the next stye follows predictably.
The diagnosis is visible to a clinician examining the lid margins under magnification: the characteristic collarettes around the lash bases, the irregular lid margin appearance, the inspissated gland secretions, and the chronic redness that distinguish blepharitis from a healthy lid margin.
Meibomian Gland Dysfunction
Meibomian gland dysfunction, commonly called MGD, is closely related to blepharitis and frequently coexists with it, but represents a distinct pathological process in the glands themselves rather than primarily at the lid margin surface.
In MGD, the secretions produced by the meibomian glands become abnormally thick and waxy rather than fluid. Healthy meibomian secretions express easily when gentle pressure is applied to the lid. In MGD, the secretions are inspissated, meaning they have the consistency of toothpaste or solidified wax, and require significant pressure to express partially. This abnormal secretion quality chronically obstructs the gland openings and creates the backup that leads to cyst formation, chalazion development, and the bacterial infection that produces styes.
MGD is progressive if not treated. The glands that are chronically obstructed and unable to express their secretions eventually undergo atrophy, losing their function permanently. This is why early identification and treatment of MGD matters beyond the stye problem: the stakes include long-term tear film health and dry eye severity as well as the recurring styes that are the presenting complaint.
The underlying conditions that cause recurring styes cover all three drivers in Miami patients: blepharitis, MGD, and ocular rosacea, including why each one creates the persistent conditions for stye recurrence and why South Florida’s warm climate makes certain presentations particularly common.
Ocular Rosacea: The Driver Most Often Missed
Rosacea is commonly understood as a skin condition affecting the face. Its ocular manifestation is less widely recognized, and it represents a significant cause of recurring styes that continues unaddressed when only the eye is evaluated without considering the patient’s broader clinical picture.
Ocular rosacea produces chronic inflammation of the eyelid margins and meibomian glands through mechanisms related to the vascular and inflammatory dysregulation that characterizes rosacea systemically. The meibomian glands in ocular rosacea patients become chronically inflamed and dysfunctional in ways that produce persistent stye recurrence, often more severe and more resistant to standard treatment than the styes produced by blepharitis or MGD alone.
The diagnosis requires recognizing the association between the patient’s facial rosacea, the characteristic telangiectasias that may be visible on the eyelid margins, and the pattern of gland inflammation that distinguishes ocular rosacea from standard blepharitis. A patient who is treated repeatedly for styes without anyone connecting them to their rosacea diagnosis is receiving incomplete care for an incompletely identified problem.
Miami’s warm climate is relevant here because heat is a known trigger for rosacea flares, and the year-round warmth of South Florida creates conditions where ocular rosacea patients face more persistent triggering than they would in cooler climates.
What Identifying the Cause Actually Changes
The treatment for recurring styes that addresses the underlying condition looks different depending on which condition is present.
Blepharitis management involves consistent lid hygiene using appropriate cleansing agents, warm compresses to soften gland secretions, and in moderate to severe cases topical or oral antibiotic therapy targeted at the bacterial component. The patient who learns a lid hygiene routine and understands why it needs to be ongoing rather than intermittent has the primary tool for managing their condition.
MGD treatment addresses the gland secretion quality and the obstruction directly. Warm compress therapy followed by lid massage helps express the thickened secretions and stimulates gland function. In-office treatments including thermal pulsation therapy provide more intensive gland expression than can be achieved at home. Omega-3 supplementation supports healthier meibomian secretion quality over time.
Ocular rosacea requires treatment that addresses both the inflammatory and the infectious components, typically involving oral doxycycline at anti-inflammatory doses alongside lid hygiene and meibomian gland treatment. Identifying the rosacea connection also allows treatment of the skin condition itself to reduce the ocular triggering.
The details of how a comprehensive eye exam identifies the recurring stye cause cover what the lid and gland evaluation reveals about blepharitis severity, meibomian gland health, and the rosacea-related findings that indicate why a patient’s styes haven’t stopped with standard treatment.
What the Evaluation Involves
An eyelid and meibomian gland evaluation as part of a comprehensive eye exam involves slit-lamp examination of the lid margins, assessment of gland expressibility, evaluation of the tear film and its stability, and in some cases meibography, which uses infrared imaging to visualize the meibomian gland structure and identify atrophy.
This evaluation is more detailed than a brief lid check during a routine exam. For patients with recurring styes, the lid margin and gland evaluation should be specific, thorough, and oriented toward identifying which of the underlying conditions is present rather than simply confirming that the current stye is resolving.
Miami Eye Doctor evaluates the eyelid margin and meibomian gland health of recurring stye patients as part of a comprehensive assessment, because identifying and treating the underlying condition is what actually stops the recurrence rather than managing each stye individually.
For Miami patients who have been through multiple styes and are ready to understand why they keep happening, scheduling an evaluation to find out what is causing your recurring styes near Miami is the starting point for treatment that addresses the right problem.
The stye is the symptom. The underlying condition is where the treatment needs to go.
